Busulfan-melphalan in high-risk neuroblastoma: the 30-year experience of a single institution. Proust-Houdemont, S.; Pasqualini, C.; Blanchard, P.; Dufour, C.; Benhamou, E.; Goma, G.; Semeraro, M.; Raquin, M. A.; Hartmann, O.; Valteau-Couanet, D.. Bone Marrow Transplant. 2016; 1076-81: p.1076-81. doi:10.1038/bmt.2016.75 10.1038/bmt.2016.75. Epub 2016 Apr 4.Article
Oncostat